Client needed help to support development of local medical launch readiness plans including local medical objectives, competitive positioning, scientific narrative, and data generation, and stakeholder engagement strategy for a new vaccine.
We developed a framework to systematically assess medical planning for the asset that included the medical objectives, competitive positioning, scientific narrative, data generation, and stakeholder engagement. Country-specific syntheses of strategic considerations were developed to inform medical planning. The significance and feasibility of supporting the asset scientific narratives were considered by country.
We provided an executive summary of the asset’s medical objectives, key scientific narratives, gaps and potential challenges, country action plans, and implications for regional and global.
Jump to a slide with the slide dots.
AI and claims data bridge health equity gaps in cardiovascular care, uncovering disparities and providing actionable solutions to improve access.
Read moreRefined HCP targeting in rare disease using integrated data, boosting hit rates from 10% to 50% and delivering 3x ROI in 6 months.
Read moreUsed GenAI to benchmark digital voice in oncology, boosting engagement & leadership via LinkedIn, DEI & clinical messaging.
Read more